[On some aspects of therapy of chronic peripheral obliterating arteriopathies (C.P.O.A.) on arteriosclerotic nature].
D000328:Adult; D000368:Aged; D001162:Arteriosclerosis Obliterans / Q000628:therapy*; D001780:Blood Coagulation Tests; D001809:Blood Viscosity / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D002908:Chronic Disease; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D010991:Plethysmography; D011725:Pyridines / Q000627:therapeutic use*; D013562:Sympathectomy; D014665:Vasodilator Agents / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D008055:Lipids; D011725:Pyridines; D014665:Vasodilator Agents; D002784:Cholesterol
Su taluni aspetti della terapia delle arteriopatie obliteranti croniche periferiche (A.O.C.P.) di natura arteriosclerotica.